Introduction to RenaissanceRe Medici UCITS Fund
RenaissanceRe has announced the launch of its latest financial venture, the RenaissanceRe Medici UCITS Fund, a sub-fund of the RenaissanceRe Medici ICAV (Medici UCITS). This new fund, domiciled in Ireland, is designed to provide European and global investors with access to RenaissanceRe’s successful catastrophe bond investment strategy.
Management and Strategic Alignment
The RenaissanceRe Capital Partners team will manage this fund, complementing the existing RenaissanceRe Medici Fund Ltd. (Medici). Both UCITS and Medici are aligned with similar investment guidelines and risk profiles, as highlighted by RenaissanceRe.
Statements from Executives
Ross Curtis, EVP and Chief Portfolio Officer of RenaissanceRe, stated, “The launch of Medici UCITS signifies our ongoing global expansion and diversification efforts, aligning with our mission to align desirable risk with both owned and partner capital. We are excited to offer a new fund to our third-party investors while ensuring vital protection for our clients.”
Christopher Parry, SVP and Global Head of Capital Partners, added, “At RenaissanceRe, we take pride in our 25-year legacy of managing third-party capital and cultivating trusted relationships with our investors. Medici UCITS, our latest offering, provides our European partners with enhanced access to the lucrative catastrophe bond market in a structure tailored to their needs. We are eager to extend the risk expertise and proprietary tools of our Medici portfolio management team to investors in this fund.”
Fund Launch and Financial Details
The Medici UCITS launched with a substantial $340 million in total capital, sourced from a blend of primarily existing partner capital, new partner capital, and a significant $140 million co-investment from RenaissanceRe itself.
As per RenaissanceRe, Medici UCITS will operate independently from RenaissanceRe’s financial results. The Central Bank of Ireland will oversee the regulation of Medici UCITS, which is expected to generate fee income. In addition, RenaissanceRe’s consolidated financial statements will account for its co-investment at fair value.
